Introduction
============

Intracranial aneurysm is a kind of severe intracranial disease mainly responsible for subarachnoid hemorrhage, and the rupture of intracranial aneurysm results in a mortality rate of 30%--40%.[@b1-cia-14-203],[@b2-cia-14-203] Although significant advance has been made in surgical operation of intracranial aneurysm, there is still poor post-operative recovery in patients with intracranial aneurysm.[@b1-cia-14-203],[@b3-cia-14-203] In addition to those related to disease itself and surgical operation, stress response, persistent pain, and metabolic demand serve as critical pathogenic factors in post-operative recovery.[@b4-cia-14-203] Enhanced recovery after surgery (ERAS) offers a series of approaches, such as professional education, nutritional care, improved anesthesia, and fluid management.[@b5-cia-14-203] ERAS protocol has been applied for various operations, such as colonic, pancreaticoduodenectomy, cystec-tomy, gastrectomy, and rectal/pelvic operation.[@b6-cia-14-203]--[@b10-cia-14-203] ERAS protocol has the chance to not only accelerate the recovery of different patients but also shorten the length of hospital stay.[@b11-cia-14-203] However, there is nearly no study to analyze the feasibility and efficacy of ERAS protocol in Chinese elderly patients with intracranial aneurysm. For the first time in the world, this study aimed to assess the feasibility and efficacy of ERAS protocol in Chinese elderly patients with intracranial aneurysm.

Methods
=======

Study patients
--------------

From January 2011 to July 2017, 300 patients at the Department of Neurosurgery, Inner Mongolia Xing'an Meng People's Hospital were recruited in this study. The inclusion criteria include the following: 1) age over 60 years; 2) medical history, clinical appearance (dizziness, headache, and nerve localization signs), and diagnostic imaging (computed tomography angiography \[CTA\] or digital subtraction angiography \[DSA\]) supported the diagnosis of intracranial aneurysm; 3) surgical treatment of intracranial aneurysm; and 4) the ability to understand and participate in this study. The exclusion criteria include the following: 1) contraindications to surgical treatment of intracranial aneurysm and 2) severe cardiac, hepatic, renal, and other systematic diseases. The study protocol has been approved by the ethics committee of Inner Mongolia Xing'an Meng People's Hospital, and it conforms to the Declaration of Helsinki. Each participant provided written informed consent to be included in the study.

Study protocol
--------------

Patients were randomly allocated to two groups as follows: ERAS group (n=150, ERAS protocol) and control group (n=150, conventional management). Surgical treatment of intracranial aneurysm was performed by united team with full experience. Patients were placed in the supine position, and operation was performed under general anesthesia. Minimally invasive surgical approach through small pterion or inferolateral forehead was applied in all patients. Intra-cranial aneurysm was treated with clipping. Operation was monitored by electroencephalogram and somatosensory evoked potential. Blood flow and its patency were assessed during the operation by microvascular Doppler ultrasound. Fluorescence angiography was applied to assess the patency of parental artery and perforating artery.

ERAS protocol
-------------

ERAS protocol was performed as shown in [Table 1](#t1-cia-14-203){ref-type="table"}.[@b12-cia-14-203] In addition to educating the patient on surgical risks and benefits as part of the control protocol, pre-operative education of the ERAS protocol included the information about appointments and instructions, testing and drugs, eating and drinking, smoking and alcohol, expectations about disposition, and surgical site care.[@b4-cia-14-203] In addition to post-operative instrument of the control protocol at clinics after discharge based on the self-determination of patients, patients received phone reminder from surgical doctors within 48 hours of discharge and every week after operation to assess pain management, identify patient concerns, and clarify follow-up instrument.

Outcome measure
---------------

All patients were followed up for 1 year, and there were no patients lost during the follow-up. The primary outcomes were assessed by the mortality and the length of hospital stay after operation (the number of days from operation to discharge) during the first year after operation. The secondary outcome was assessed by the readmission during the first year after operation. Glasgow Outcome Scale (GOS) and Modified Rankin Scale (MRS) were applied to assess neurological function and prognostic performance at discharge and the first year after operation.

Statistical analyses
--------------------

Continuous variables with normal distribution were described using mean and SD and compared between two groups using Student's *t*-test. Continuous variables with skewed distribution were described using median and IQR and compared between two groups using the Mann--Whitney *U* test. Categorical variables were described with number and percentage and compared between two groups using the chi-squared test. Statistical analysis was performed using SPSS 18.0 software (SPSS Inc., Chicago, IL, USA). *P*\<0.05 was considered to be statistically significant.

Results
=======

Age of whole cohort was 65 (64--67) years with 140 males (46.7%). As shown in [Table 2](#t2-cia-14-203){ref-type="table"}, there was no difference between two groups in baseline features of patients, such as age, sex, medical histories, percentages of aneurysmal location, aneurysmal number \>1 per patient, aneurysmal diameter \>5 mm, or lobular aneurysm (*P*\>0.05 for all). Clinical outcomes of patients were compared between two groups in [Table 3](#t3-cia-14-203){ref-type="table"}. There was no occurrence of death in two groups. Compared with those in the control group, patients in the ERAS group had significantly shorter length of hospital stay (*P*\<0.05). Between two groups, patients had not only similar GOS and MRS at discharge but also occurrence of readmission at follow-up (*P*\>0.05 for all). Patients in the ERAS group had significantly higher GOS and lower MRS at follow-up (*P*\<0.05 for all).

Discussion
==========

Intracranial aneurysm is a kind of severe intracranial disease mainly responsible for subarachnoid hemorrhage, and the rupture of intracranial aneurysm results in a mortality rate of 30%--40%.[@b1-cia-14-203],[@b2-cia-14-203] Although significant advance has been made in surgical operation of intracranial aneurysm, there is still poor post-operative recovery in patients with intracranial aneurysm.[@b1-cia-14-203],[@b3-cia-14-203] Surgical treatment of intracranial aneurysm often requires complex operation, as well as careful preoperative preparation, intraoperative care, and post-operative management.[@b12-cia-14-203] Enhanced recovery is significant in patients with intracranial aneurysm but evidence-based protocol on perioperative care for this population is lacking. For the first time in the world, this study confirmed that the ERAS protocol significantly shortened the length of hospital stay and improved GOS and MRS without any increase in the mortality or readmission in Chinese elderly patients with intracranial aneurysm.

Stress response, persistent pain, and metabolic demand related to surgical operation delay the recovery of patients after operation.[@b4-cia-14-203] ERAS protocol has been introduced as a way of optimizing perioperative care for different operations, such as colonic, pancreaticoduodenectomy, cystectomy, gastrectomy, and rectal/pelvic operation.[@b6-cia-14-203]--[@b10-cia-14-203] Improving perioperative care in an evidence-based and structured manner is the primary goal of the ERAS protocol. Evaluation of the ERAS protocol in patients with these diseases has shown that these patients had shorter length of hospital stay and experienced significant improvements in recovery after operation.[@b12-cia-14-203] ERAS protocol has revolutionized the way of perioperative care in surgical field. However, no evidence has been offered to support the ERAS protocol in Chinese elderly patients with intracranial aneurysm. In this study, the ERAS protocol offers a series of approaches, such as professional education, nutritional care, improved anesthesia, and fluid management.[@b5-cia-14-203] It is no surprise for these approaches to alleviate stress response, persistent pain, and metabolic demand related to surgical operation and promote the recovery of patients with intracranial aneurysm after operation.[@b12-cia-14-203]

Conclusion
==========

For the first time in the world, this study demonstrated that the ERAS protocol significantly shortened the length of hospital stay and improved GOS and MRS without any increase in the mortality or readmission in Chinese elderly patients with intracranial aneurysm.
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###### 

ERAS strategy performed in this study

  Strategy                            Control group                          ERAS group
  ----------------------------------- -------------------------------------- ----------------------------------------------------------------
  **Preoperative**                                                           
  Preoperative education              Conventional                           Detailed (ERAS strategy)
  Oral diet                           Nothing for 8 hours before operation   Fluids until 2 hours and solids until 6 hours before operation
  Short-acting anxiolytics            Occasionally                           Conventional
  Corticosteroid and antiemetic       Occasionally                           Conventional
  **Operative**                                                              
  Patient-controlled analgesia pump   No                                     Yes
  Nasogastric tube                    Conventional                           Minimized
  Room temperature                    Conventional                           \>25°C
  Heated liquid                       No                                     Yes
  Warm air                            No                                     Yes
  Fluid administration                Conventional                           Goal-directed manner
  **Postoperative**                                                          
  Urinary catheter removal            Three days after operation             One day after operation
  Water                               Twelve hours after operation           Six hours after operation
  Liquid food                         Two days after operation               One day after operation
  Semiliquid diet                     Three or four days after operation     Two days after operation
  Normal diet                         Five or six days after operation       Three days after operation
  Fluid administration                Conventional                           Restricted (\<2,500 mL)
  Patient-controlled analgesia pump   No                                     Yes
  Pulmonary physical therapy          No                                     Conventional
  Instrument after discharge          Self-determination of patients         Phone reminder, detailed and frequent

**Abbreviation:** ERAS, enhanced recovery after surgery.

###### 

Baseline features of all patients divided into ERAS and control groups

  Features                                                  All patients (n=300)   Control group (n=150)   ERAS group (n=150)   *P*-value
  --------------------------------------------------------- ---------------------- ----------------------- -------------------- -----------
  Age, years                                                65 (64--67)            65 (64--67)             65 (64--68)          0.451
  Males, n (%)                                              140 (46.7)             69 (46.0)               71 (47.3)            0.817
  Hypertension, n (%)                                       158 (52.7)             77 (51.3)               81 (54.0)            0.644
  Diabetes mellitus, n (%)                                  85 (28.3)              39 (26.0)               46 (30.7)            0.370
  **Aneurysmal location, n (%)**                                                                                                0.705
  Posterior communicating and anterior choroidal aneurysm   151 (50.3)             79 (52.7)               72 (48.0)            
  Middle cerebral aneurysm                                  70 (23.3)              34 (22.7)               36 (24.0)            
  Anterior communicating aneurysm                           79 (26.3)              37 (24.7)               42 (28.0)            
  Aneurysmal number \>1 per patient, n (%)                  21 (7.0)               10 (6.7)                11 (7.3)             0.821
  Aneurysmal diameter \>5 mm, n (%)                         63 (21.0)              29 (19.3)               34 (22.7)            0.478
  Lobular aneurysm, n (%)                                   84 (28.0)              38 (25.3)               46 (30.7)            0.304

**Abbreviation:** ERAS, enhanced recovery after surgery.

###### 

Clinical outcomes of all patients divided into ERAS and control groups

  Outcomes                        Control group (n=150)   ERAS group (n=150)   *P*-value
  ------------------------------- ----------------------- -------------------- -----------
  Length of hospital stay, days   10 (8--12)              9 (7--11)            0.019
  Readmission, n (%)              4 (2.7)                 2 (1.3)              0.680
  **GOS at discharge, n (%)**                                                  
  5                               143 (95.3)              147 (98.0)           0.198
  4                               7 (4.7)                 3 (2.0)              
  **MRS at discharge, n (%)**                                                  
  0--1                            134 (89.3)              143 (95.3)           0.148
  2                               9 (6.0)                 4 (2.7)              
  3                               7 (4.7)                 3 (2.0)              
  **GOS at follow-up, n (%)**                                                  
  5                               138 (92.0)              146 (97.3)           0.040
  4                               12 (8.0)                4 (2.7)              
  **MRS at follow-up, n (%)**                                                  
  0--1                            126 (84.0)              140 (93.3)           0.034
  2                               12 (8.0)                6 (4.0)              
  3                               12 (8.0)                4 (2.7)              

**Abbreviations:** ERAS, enhanced recovery after surgery; GOS, Glasgow Outcome Scale; MRS, Modified Rankin Scale.
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